Artificial intelligence-based telemedicine platform may allow for large-scale screening of patients with age-related macular degeneration while lowering the cost of care, according to a poster at AAO Annual Meeting.
The positive results of this study permit for further clinical validation of AI-powered telemedicine as well as potential widespread deployment.
“We have focused on AMD because late AMD is the leading cause of blindness in the developed countries,” Sharmina Alauddin, FCPS, said in her virtual presentation. “Our study is the first of an AI fundus photo-based
Uncategorized